May 30, 2018
One investor backed by Glancy Prongay & Murray LLP is competing with another represented by Levi & Korsinsky LLP in separate bids filed in Massachusetts federal court Tuesday to be named lead plaintiff in a proposed class action accusing a bioscience company of withholding information about the toxicity of its signature muscular dystrophy treatment ahead of its initial public offering.
March 28, 2018
Solid Biosciences Inc. has been accused of securities fraud in a Massachusetts federal lawsuit filed Tuesday by a putative class of investors who claim the company was not forthcoming about the toxicity of its signature muscular dystrophy treatment ahead of its initial public offering, leading to stock drops once its risks were revealed.